Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1925 1
1927 1
1957 4
1958 2
1959 1
1960 4
1961 7
1962 7
1963 9
1964 13
1965 13
1966 12
1967 5
1968 13
1969 17
1970 21
1971 14
1972 18
1973 14
1974 17
1975 24
1976 30
1977 28
1978 27
1979 37
1980 34
1981 48
1982 31
1983 48
1984 40
1985 39
1986 37
1987 52
1988 28
1989 51
1990 54
1991 55
1992 49
1993 49
1994 53
1995 56
1996 62
1997 57
1998 65
1999 70
2000 56
2001 63
2002 64
2003 92
2004 86
2005 98
2006 110
2007 116
2008 113
2009 138
2010 164
2011 222
2012 246
2013 267
2014 261
2015 335
2016 349
2017 364
2018 380
2019 413
2020 510
2021 545
2022 541
2023 527
2024 524
2025 610
2026 394

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,951 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean shan p[au] (444 results)?
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial.
Bajaj HS, Welch M, Shah P, Luna E, Jaouimaa FZ, Liu B, Liu R, Chen Y, Patel H, Bartee A. Bajaj HS, et al. Among authors: shah p. Lancet. 2026 Jun 13;407(10546):2402-2413. doi: 10.1016/S0140-6736(26)00967-0. Epub 2026 Jun 6. Lancet. 2026. PMID: 42250575 Clinical Trial.
Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy.
Touzeau C, Mina R, Quach H, Hungria V, Bhutani D, Chen W, Kumar S, Chaulagain C, Dimopoulos MA, Bahlis NJ, Maral S, van de Donk NWCJ, Schmidt Filho J, Saja K, Teipel R, Ando M, Roeloffzen W, Annibali O, Augustson B, Botta C, Delforge M, Bourgeois E, Buda G, Hus M, Perrot A, Preis M, Beksac M, Pour L, Farmer S, Nunes M, Oriol A, Melchardt T, Hu Y, Flogegård M, Wang D, Pei L, Wroblewski S, Ariës IM, Quijano Cardé NA, Perova T, de Jager T, Yeh TM, Vanquickelberghe V, Shah P, Chastain K, Kobos R, Carson R, Landgren O; MajesTEC-9 Trial Investigators. Touzeau C, et al. Among authors: shah p. N Engl J Med. 2026 Jul 30;395(5):440-453. doi: 10.1056/NEJMoa2603870. Epub 2026 May 29. N Engl J Med. 2026. PMID: 42212933 Clinical Trial.
MTAP Deletion in Oncogenesis: A Synthetic Lethality Scenario.
Rodon J, Johnson ML, George B, Shah PA, Arbour KC. Rodon J, et al. Among authors: shah pa. Cancer Res. 2026 Apr 2;86(7):1558-1569. doi: 10.1158/0008-5472.CAN-25-2126. Cancer Res. 2026. PMID: 41512197 Free PMC article. Review.
Improving dual targeting selectivity in T-cell engagers via synapse-gated and affinity-tuned trispecific antibody design.
Zhao P, Schardt J, Chiang CI, Shah P, Eun GS, Martinek J, Cyr M, Johnson Y, Amofah B, Ye X, Edwards S, Chen X, Penney M, Liu W, Yang C, Rickert K, Lee A, Payne S, Zhang H, Kelly G, Wang C, Gerber A, Mulgrew K, Varma R, Boyd J, Li X, Bagert JD, Walseng E, Mazor Y. Zhao P, et al. Among authors: shah p. MAbs. 2025 Dec;17(1):2570748. doi: 10.1080/19420862.2025.2570748. Epub 2025 Oct 8. MAbs. 2025. PMID: 41058481 Free PMC article.
Editorial Comment.
Shah PV, Koehne EL. Shah PV, et al. J Urol. 2026 Mar;215(3):313-314. doi: 10.1097/JU.0000000000004866. Epub 2026 Feb 9. J Urol. 2026. PMID: 41660738 No abstract available.
Authors' reply.
Courtwright AM, Mackintosh JA, Alder JK, Garcia CK, Froidure A, Lowery E, Hayes D Jr, Shah P, Philippot Q, Borie R, Greenland JR, Mannem H, Snyder ME, Hellemons M, Snyder LD, McDyer J. Courtwright AM, et al. Among authors: shah p. J Heart Lung Transplant. 2026 Jun;45(6):1016. doi: 10.1016/j.healun.2026.02.1672. Epub 2026 Feb 25. J Heart Lung Transplant. 2026. PMID: 41759645 No abstract available.
Establishing the relationship between brain cellular senescence and brain structure.
Lund AN, Kopell BH, Golestani N, Vornholt E, Thompson RC, Liharska LE, Luo Y, Cheng E, Park YJ, Fennessy B, Wilkins L, Kaji DA, Silk H, Ziafat K, Hashemi A, Moya E, Feng C, Linares LM, Grice AB, Xie S, Rieder MK, Scarpa J, Kota P, Cohen V, Sullivan B, Shah P, Ma W, Johnson JS, Miller GM, Searfoss R, Chand NM, Wang P, Nadkarni GN, Narain NR, Nestler EJ, Kiebish MA, Schadt EE, Charney AW, Beckmann ND. Lund AN, et al. Among authors: shah p. Cell. 2026 Jan 22;189(2):511-527.e17. doi: 10.1016/j.cell.2025.10.014. Cell. 2026. PMID: 41576919 Free PMC article.
Case 347.
Gaddikeri R, Shah P. Gaddikeri R, et al. Among authors: shah p. Radiology. 2026 Feb;318(2):e251896. doi: 10.1148/radiol.251896. Radiology. 2026. PMID: 41733470
Cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinoma.
Chalabi Hajkarim M, May M, Amin AD, Jamison J, Tagore S, D'Souza E, Caprio L, Walsh ZH, Fan JL, Zhang M, Shah P, Abuzaid S, Michel A, Dajiang S, Wong W, Shaikh N, Ramaradj P, Bakir B, Kluger MD, Chabot J, Azizi E, Hibshoosh H, Rustgi AK, Raufi AG, Manji GA, Izar B. Chalabi Hajkarim M, et al. Among authors: shah p. Nat Genet. 2025 Nov;57(11):2728-2742. doi: 10.1038/s41588-025-02345-5. Epub 2025 Oct 27. Nat Genet. 2025. PMID: 41145870 Free PMC article.
7,951 results